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1 Division of Immunology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Huis, Plesmanlaan 121, 
1066 CX Amsterdam; and 2 Department of Pathology, Medical School, University of Leiden, Leiden, The 
Netherlands.
The functional properties of the melanoma-associ­
ated antigens detected by monoclonal antibodies 
(MAbs) AMF-6 and AMF-7 were investigated. These 
MAbs were selected previously because of their capac­
ity to block the anti-melanoma reactivity of cytotoxic 
T-lymphocyte clones A M F -6 and AMF-7 detect a me(- 
anoma-associated proteoglycan (MW > 450 - 250 kDa) 
and a molecular complex, which under reducing con­
ditions consists of 4 compounds of 120, 95, 29 and 25 
kDa respectively. A M F -6 reacted strongly with all 30 
cultured melanomas and all 41 melanomas in frozen 
tissue sections. Significant cross-reactivity was only 
observed with nevi and perineurium, whereas normal 
skin melanocytes were negative. AMF-7 reacted with 
all 25 cultured melanomas and all 34 melanomas in 
frozen sections. AMF-7 cross-reacted with a propor­
tion of nevi and endothelial cells from small vessels. 
The antigen detected by AM F -6 and AMF-7 could not 
be modulated by retinoic acid or recombinant 7 -IFN, 
which induced or enhanced the expression of HLA- 
DR, H LA -D Q  and Class-1 M HC antigens. In addition, 
the antigens were not readily modulated when cells 
were incubated in excess amounts of AMF-6 and AMF- 
7. Interestingly, the antigen detected by AMF-7 was 
strongly associated with the adhesion and cytoplasmic 
spreading of melanoma cells to plastic surfaces and 
monolayers of vascular endothelial cells. AMF-6 did 
not block the adhesion of melanoma cells but delayed 
cytoplasmic spreading. Both AMF-6 and AMF-7 
blocked fibronectin-induced chemotaxic motility and 
chemokinesis of melanoma cells. In addition to their 
membrane localization, the antigens detected by AMF-
6 and AMF-7 were also abundant in extracellular adhe­
sion plaques deposited by cultured melanoma ceils.
Our results indicate that the high-MW melanoma- 
associated proteoglycan and the antigen detected by 
AMF-7 are associated with adhesion and/or cyto­
plasmic spreading and m otility of human melanoma 
cells, suggesting that these antigens ¿ire associated with 
the (hematogenic) dissemination of human mela­
noma« This is supported by the finding that AMF-7 
stained primary tumors heterogeneously, whereas 
metastases were homogeneously stained.
Recently, MAbs reacting with antigens on murine 
and human melanoma cells that are associated with the 
adhesion and motility of these cells have been de­
scribed (Vollmers and Birchmeier, 1983a,b\ Dippold 
et al., 1984; Cheresh et al., 1984). Both cell-cell 
adhesion and cell motility are important factors in the 
process of metastasis (reviewed by Fidler and Nicol- 
son, 1980; and Nicolson, 1982, 1984).
One critical step in hematogenic metastasis is that 
blood-borne tumor cells are arrested in the microcir- 
culation by attachment to vascular endothelium (Kra­
mer and Nicolson, 1979; Kramer et a l 1980; 
Terranova et aL , 1983). After this adhesion step, ex­
travasation occurs and the tumor cells invade the un­
derlying basement membrane and tissues (Kramer et 
a l 1980; Nicolson, 1982). Tumor cells probably uti­
lize several mechanisms to penetrate normal tissue
(Nicolson, 1982), but active tumor-cell motility also 
contributes to the invasive process (Poste and Fidler,. 
1980; Haemmerli et a l 1982; Volk et aL, 1984). 
Therefore MAbs that block adhesion, motility and 
migration of tumor cells may detect antigens which are 
associated with the hematogenic dissemination of these 
tumors. Indeed, Vollmers and Birchmeier (1983a,b) 
observed that MAbs against B16 mouse melanoma, 
which were selected for their capacity to block the 
adhesion of B16 cells, also inhibited the formation of 
lung metastasis in vivo. These anti~B16 MAbs were 
not specific. Cross-reactivity was observed with a large 
variety of malignant and virally transformed cells of 
both murine and human origin (including melanoma), 
but not with non-transformed cells (Vollmers and 
Birchmeier, 1983b).
Other MAbs that detect antigens associated with 
adhesion of human melanoma cells include MAb R24 
which reacts with the GD3 ganglioside present on 
melanomas, melanocytes, astrocytomas, astrocytes and 
subsets of sarcomas. R24 causes melanoma cells to 
aggregate and to detach from plastic surfaces (Dippold 
et a l 1984). GD3 gangliosides can be considered as 
cellular adhesion molecules, since this molecule is 
present in the extracellular adhesion plaques deposited 
by human melanoma cells at the interface between the 
tumor cells and their substrate (Cheresh et al., 1984).
In the present study we describe 2 MAbs, AMF-7 
and PAF-1, which detect the same melanoma-associ­
ated surface antigen. This antigen is associated with 
adhesion, spreading and motility of human melanoma 
cells. The last two properties were also blocked by 
another MAb (AMF-6) which detects a melanoma- 
associated high-molecular-weight proteoglycan. These 
results indicate that the antigens detected by these 
MAbs may be associated with metastasis.
This notion is supported by the in vivo distribution 
of the antigen detected by AMF-7. Primary tumors 
stained heterogeneously contained AMF-7-negative 
cells, whereas metastases were stained homogeneously.
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MATERIAL AND METHODS
Cells and cell lines
Melanoma cells were derived from both short-term 
cultures and long-term cell lines established in our 
laboratory (De Vries et al., 1972). The short-term- 
cultured (4 weeks in culture, 6th passage) BK mela­
noma cells used to immunize mice for MAb production 
were obtained from a cervical lymph-node metastasis 
o f  a 44-year-old male patient. All melanoma cells and 
the other adherent cell cultures derived from normal 
and non-melanoma tumor tissue were cultured in Dul- 
becco’s modification of Eagle’s minimal essential me­
dium (DMMEM) supplemented with streptomycin (50 
/xg/ml), penicillin (100 IU/ml), NaF^CC^ (2 g/1 ), glu­
tamine (2 mM) and 10% FCS (GIBCO, Glasgow, Scot­
land). The mammary carcinoma cell cultures used in 
this study were also supplemented with insulin (5 /xg/ 
ml). The EBV-transformed B-cell lines, the T leu­
kemic cell lines and the myeloid leukemia cell lines 
were cultured in serum-free medium (Yssel et al., 
1984a). Normal T lymphoblasts were grown in serum- 
free medium in the presence of interleukin-2 and an 
irradiated feeder cell mixture (Spits et al., 1982a,b). 
Vascular endothelium cell cultures were derived from 
human umbilical veins (Jaffe et al., 1973). The cells 
were cultured in Iscove’s medium supplemented with 
10% human serum, 3.3 X 10” 5 M isobutyl methylxan- 
thine and 5 x 10“ 4  m dibutyryl cyclic AMP.
Production and selection o f MAbs against melanoma
BALB/c mice were immunized with BK melanoma 
cells (Spits et al., 1984b). Hybridomas reacting with 
melanoma cell surface antigens and not with autolo­
gous T lymphoblasts were selected for further testing 
and finally screened for their capacity to inhibit the 
cytotoxic reactivity of a CTL clone against autologous 
BK melanoma cells. The hybridomas producing these 
antibodies were cloned and subcloned at concentra­
tions of 0.5 cells/well in 96-well microtiter plates and 
injected into pristane (2,6,10,14 tetramethyl pentade- 
cane)~treated B ALB/c mice for ascites production. Two 
MAbs, AMF-6 (IgGl) and AMF-7 (IgGl), which in­
hibit the cytotoxic effects of CTL clones with anti­
melanoma reactivity (data not shown) were selected 
for investigation of their effects on the biological func­
tions of human melanoma cells. AMF-6 was shown to 
precipitate a molecular complex consisting of 2 bands 
with MW of more than 450 and 250 kDa, respectively, 
like the melanoma-associated proteoglycan described 
by others (Natali et al., 1981; Bumol and Reisfeld, 
1982). AMF-7 reacts under non-reducing conditions 
with a molecular complex consisting of 2 bands having 
MWs of 150 and 90 kDa, respectively. Under reducing 
conditions the antigen detected by AMF-7 consists of 
4  subunits with MWs of 120, 95, 29 and 25 kDa (data 
not shown). PAF-1 is an MAb raised against short­
term cultured BK melanoma cells on a different occa­
sion. The selection protocol was similar to that de­
scribed above for AMF-7, except that the last selection 
step comprised a screening of the supernatants for their 
capacity to prevent adhesion of melanoma cells to 
plastic surfaces. Immune precipitation showed that 
PAF-1 detected the same 150- to 95-kDa antigen as did 
AMF-7 (data not shown).
Monoclonal antibodies
The MAb W6/32 which reacts with a framework 
determinant on HLA-A, B and C was obtained from 
Sera-Lab, Crawley Down, UK. Q 5/13 directed against 
HLA-DR (Quaranta et al., 1980) was kindly provided 
by Dr. S. Ferrone (Valhalla, NY). SPV-L3, which 
reacts with HLA-DQ, was produced in our laboratory 
(Spits et al., 1984a). AMF-2 was raised in our labo­
ratory and reacts with a 22-kDa surface antigen ex­
pressed on melanoma and a variety of other cells 
including neuroblastomas, other non-melanoma tu­
mors, EBV-transformed B-cell lines and normal tis­
sues. AMF-8 (IgGl) was raised in our laboratory and 
also reacts with a melanoma surface antigen whose 
MW has not yet been determined. As far as tested, 
AMF-8 is not melanoma-restricted and it cross-reacted 
with EBV-transformed B-cell lines and myeloid leu­
kemia cell lines. PA-LM1 (IgGl) and PA-LM2 (IgGl) 
were obtained from Dr. D. Ruiter (Leiden, The Neth­
erlands) . Both antibodies react with melanoma-associ­
ated antigens (Ruiter et al., 1985). PA-LM2 detects an 
antigen consisting of 2 subunits with estimated MWs 
of 100 and 95 kDa, which is preferentially expressed 
on melanomas and not on nevi (Ruiter et al., 1985). 
The MW of the antigen detected by PA-LM1 has not 
yet been determined. The MAb 96.5, which reacts 
with the melanoma-associated p97 antigen (Hellstrom 
et al., 1982), was kindly provided by Drs. I. and K.E. 
Hellstrom (Seattle, WA). OKT-9, which is directed 
against the transferrin receptor (Trowbridge and 
Omary, 1981) was purchased from Ortho, Raritan, NJ.
Membrane immunofluorescence
Membrane immunofluorescence on cultured cells 
and cell lines was carried out as described previously 
(Yssel et al., 1984b). Adherent cells were detached 
with EDTA, resuspended in DMEM + 10% FCS, and 
incubated for 1 hr with occasional shaking. After 
washing with PBS containing 0.5% BSA and azide 
(0.1%), 5 X 105 cells were incubated for 20 min at 
0°C with the MAb at a dilution of ascites of 1:2,000 
to 1:5,000. After this incubation period the cells were 
washed 3 times with PBS (0.5% BSA and azide) and 
incubated with FITC-labelled GAM-Ig (1:20 diluted, 
Nordic, Tilburg, The Netherlands) for 20 min at 0°C. 
Subsequently, the cells were washed 3 more times with 
PBS and analyzed with a FACS (FACS IV, Becton- 
Dickinson, Mountain View, CA).
Detection of extracellular matrix by 
immunofluorescence
For analysis of the extracellular matrix, melanoma 
cells were cultured on glass coverslips for 24-48 hr. 
Melanoma cells were carefully detached with EDTA 
and their removal was checked microscopically. 
Coverslips were incubated with MAbs, then washed, 
stained with GAM-Ig FITC and examined with a fluo­
rescence microscope,
Immunoperoxidase staining of frozen tissue sections
For immunoperoxidase staining of frozen sections 
(Ruiter et al., 1985), frozen sections (4 /x) were air- 
dried and fixed in acetone for 10 min. MAbs were 
added at an appropriate dilution and incubated for 60 
min at room temperature. The sections were washed
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TABLE I -  DISTRIBUTION OF THE MELANOMA-ASSOCIATED ANTIGENS DETECTED BY MAbs AMF-6 AND AMF-7
Melanoma Non-melanoma tumor Normal cells/tissues
MAb Primary Métastasés Membrane
IF
Frozen
sections
Membrane
IF
Frozen
sectionsMembrane Frozen 
IF sections
Membrane
IF
Frozen
sections
AMF-6 2/2 6/6 28/28 35/35 0/2 2 1 0/ 122 0/223 2/7 14
AMF-7 2/2 5/5 15/15 29/29 0/2 i s 0/ 12 2 0/156 3/557
'including: 3 neuroblastomas, 2 mammary carcinomas, 2 oat-cell carcinomas, I bladder carcinoma, I teratocarcinoma, I cervix carcinoma, 3 myeloid 
leukemias, I erythroid leukemia, 3 T-cell leukemias, 2 Burkitt lymphomas, 2 B lymphomas, and B-16 murine melanoma,-2Including: 2 ovarian 
carcinomas, 2 colon carcinomas, 2 lung carcinomas, 1 neurinoma, 1 thyroid carcinoma, 1  neuroblastomas and 2 mammary carcinomas.-Including: 5 
EBV-transformed B-cell lines, 6 T lymphoblast, 3 normal skin fibroblast, I normal liver cell, 1 normal bladder cell, 2 vascular endothelial cell, 3 
monocyte, 1 melanocyte culture(s)-4Positive reactions were observed with 5/6 naevi, 2/2 perineurium.-5As under 1 except that AMF-7 was only tested 
on one B lymphoma.-6Similar to 3 except that AMF-7 was tested on 3 EBV-transformed B-cell lines, 3 T lymphoblast and 2 normal skin fibroblast 
cultures.-7Positive reactions were observed with endothelial cells of small vessels, 8/17 nevi and weak reactivity with 4/5 hair follicles.
in phosphate-buffered saline (pH 7.4) and subsequently 
incubated with rabbit anti-mouse immunoglobulin- 
horseradish peroxidase conjugate (Dako, Copenhagen, 
Denmark). Tissue sections were washed and stained 
by incubation in acetate-buffered (pH 5.0) 3-amino-9- 
ethylcarbazole (Aldrich, Milwaukee, WI), dimethyl 
formamide and hydrogen peroxide, After washing with 
acetate buffer, sections were counterstained in May­
er’s hematoxylin and mounted in Aquamount (Gurr,
B.D.H., Poole, UK),
Adhesion of melanoma cells to plastic surfaces and 
monolayers of vascular endothelial cells
The adhesion of melanoma cells to plastic surfaces 
or monolayers of vascular endothelial cells was mea­
sured in an ELISA. MAb SPV-L8, which detects a 
framework determinant on HLA-B and which reacts 
with all cultured melanoma celts tested, was directly 
labelled with horseradish peroxidase (HRPO, Sigma, 
type VI). Before labelling with HRPO, mouse SPV~ 
L8 ascites was purified by ammonium sulfate precipi­
tation. Melanoma cells were detached with EDTA, 
washed with PBS and allowed to recover in DMEM + 
10% FCS and 20 mM HEPES for 1 hr at 37° C with 
occasional shaking. Melanoma cells 5 x 106 were 
incubated with 150 (i\ HRPO-labelled SPV-L8 at a 
dilution of 1:50 for 45 min at 0°C. After 3 washings, 
100 (A culture medium containing 5 X 103 melanoma 
cells were seeded in 0.2-ml wells (Costar, 3596, Cam­
bridge, MA) in the presence or absence of the MAbs 
to be tested. Unless stated otherwise, the MAbs were 
tested at dilutions of 1:200 of ascites. In our standard 
assay, melanoma cells were allowed to adhere for 4 hr 
at 37°C and 5% CO2. In the absence of MAbs the 
majority (60-80%) of the cells of melanoma cultures 
adhered to plastic during this incubation period. Some 
melanoma cultures (MEWO, KEU and GEVA) re­
quired longer incubation times (up to 10 hr) before the 
majority of cells attached. After 4 hr incubation in 
general, approximately 10- 20% of melanoma cells at­
tached. After the 4-hr incubation period, the wells 
were gently rinsed twice with warm (37 °C) PBS + 
0.2% BSA to remove non-adherent cells. The adherent 
cells were stained with 100 /xl containing 10 “ 2 ng 
TMB (3,3',5,5'-tetramethylbenzidine, crystalline, 
Sigma, St. Louis, MO). The reaction was stopped after 
5-60 min incubation (depending on the intensity of the 
color of the substrate) by adding 100 ¿d 0.8 m H2SO4. 
The intensity of the color was measured in a multiscan 
photo-spectrometer (Titertek, Skatron, Lier, Norway)
at a wavelength of 450 nm, Wells in which no cells 
were seeded served as controls. The staining corre­
lated directly with the number of adherent cells as 
determined by a standard calibration curve (not 
shown). The value obtained with cells incubated in the 
absence of MAbs was set at 100 %. Adhesion of mela­
noma cells to vascular endothelial cells was carried out 
similarly in microtiter wells containing confluent 
monolayers of endothelial cells.
Migration and motility o f melanoma cells
The motility of melanoma cells was measured in a 
48-well micro-chemotaxis assembly (NeuroProbe, Be- 
thesda, MD). The bottom wells were filled with 25 pd 
of medium with or without human plasma-derived fi- 
bronectin (300 /¿g/ml, Armour, Kankakee, IL) which 
was used as a chemo-attractant (Lacovara et al., 1984), 
Subsequently, 10-^m thick, 8 -/am  pore diameter poly­
carbonate membranes without PVP coating (Nucleo- 
pore, Pleasanton, CA) were fixed in place to separate 
bottom from top wells, and 2.5 X  10 melanoma cells 
in 50 ¿11 medium containing 2% human serum were 
added to the top wells in the presence or absence of 
MAbs. Melanoma cells were detached with EDTA and 
allowed to recover by incubating in medium for 1 hr 
at 37°C, 5% CO2 with occasional shaking. Random 
migration (bottom and top wells containing medium 
only), chemokinesis (bottom and top wells both con­
taining medium with fibronectin), and chemotaxis (only 
bottom wells containing medium with fibronectin) were 
determined after 2-6 hr incubation at 37 °C and 5% 
C 0 2. The number of cells that migrated through the 
filter and adhered to the underside of the filter were 
quantified after the cells on top of the filter were wiped 
off. The filter was air-dried and the cells were stained 
with Coomassie blue and counted microscopically.
RESULTS
Distribution of the antigens detected by AMF-6 
and AMF-7
Membrane immunofluorescence studies showed that 
AMF-6 (IgGl) and AMF-7 (IgGl) reacted strongly 
with 30/30 and 25/25 melanoma cells respectively, 
both derived from cell lines and short-term cultures. 
No reactivity was observed with cell cultures derived 
from non-melanoma tumor or normal tissues (includ­
ing 3 neuroblastomas which, like melanomas, are of 
neurectodermal origin) and cultured vascular endothe­
lial cells derived from umbilical veins (Table I). In
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F i g u r e  1 -  Primary skin melanoma stained with A M F -7  
showing marked variation in staining intensity between dif­
ferent melanoma nodules (M). Endothelial cells of adjacent 
capillaries also stain (arrows). E =  epidermis, I = inflam­
matory infiltrate. Hematoxylin counterstaining.
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F ig u r e  2 -  Melanoma metastasis showing marked diffuse 
staining with AMF-7. Endothelial cells also stain (arrows). 
Hematoxylin counterstaining.
addition, AMF-7 failed to stain murine B16 melanoma 
cells. AMF-6 and AMF-7 also reacted with 41/41 and 
34/34 melanomas in immune-peroxidase-stained fro­
zen tissue sections. AMF-7 showed significant cross­
reactivity with endothelial cells of very small vessels 
(Fig. 1), but not with those of large vessels, and with 
a proportion of the nevi. AMF-6 also reacted with 
perineurium and most nevi, and showed weak reactiv­
ity with hair follicles. Normal skin melanocytes were 
negative. A striking observation was that AMF-7 
stained primary tumors heterogeneously. Sometimes 
considerable percentages of negatively and very weakly 
stained cells were observed (Fig. 1), whereas metas­
tasis stained homogeneously (Fig. 2).
Modulation o f the antigen detected by AMF-7
In order to investigate whether the antigen could be 
modulated, melanoma cells were incubated with re­
combinant 7 -IFN (kindly provided by Dr. H. Schellek- 
ens, TNO, Rijswijk, The Netherlands) or retinoic acid. 
Incubation for 48 hr with 7 -IFN (500 U/ml) or retinoic 
acid (10“ 6 m )  had no effect on the expression of AMF- 
7. Similarly, the expression of antigens detected by 
AMF-2, AMF-6 and AMF-8, and the transferrin re­
ceptor on the melanoma cells as detected by OKT-9 
were not affected, even after incubation periods of up
to 6 days (not shown). In contrast, in all melanoma 
cultures, a strong induction or increase in the expres­
sion of HLA-DR was observed after 24-48 hr incuba­
tion with 500 U 7-IFN (Table H). DQ antigens as 
detected by MAb SPV-L3 were absent from melanoma 
cells but incubation with 7 -IFN induced the expression 
of HLA-DQ in 6/9 melanomas. Retinoic acid induced 
DR expression but had no effect on the expression of 
HLA-DQ. This indicates not only that HLA-DR and 
HLA-DQ on melanoma cells are differently expressed, 
but that their expression is also regulated differently. 
The expression of Class-I MHC antigens was already 
high, but both 7 -IFN and retinoic acid generally in­
duced an increase in the expression of these antigens 
(Tables II and III), Cultivation of melanoma cells in 
the presence of an excess of AMF-6 or AMF-7 for 
periods up to 6 hr did not result in modulation of the 
antigen, although in some melanoma cultures cap and 
patch formation was observed (not shown).
The effects o f AMF-6 and AMF-7 on adhesion of , 
melanoma cells to plastic surfaces and monolayers of 
vascular endothelial cells
The effects of AMF-6 and AMF-7 on adhesion of 
various melanoma cells derived from short-term cul­
tures and cell lines was tested with an ELISA. AMF-7
TABLE II -  EFFECT OF RECOMBINANT 7-IFN ON EXPRESSION OF THE ANTIGEN DETECTED BY AMF-7
AND CLASS-I AND CLASS-II MHC ANTIGENS
Melanoma 
culture1
AMF-7
Channel No.
HLA-DR 
with maximal
HLA-DQ
fluorescence
HLA-A,B,C
intensity
L-2 130 (—2)3 174 (25) ' 65 (33) 214 ( -1 2 )
BK 80 ( - 8 ) 165 (136) 69 (46) 181 (20)
Hor 86 (6) 127 (100) 27 ( — 5) 221 (18)
Keu 150 ( - 8 ) 171 (143) 125 (94) 220 (18)
NKI-4 137 ( - 7 ) 168(113) * 69 (28) 198 ( -1 4 )
NK1-1 157 ( - 4 ) 196 (133) 118(71) 229 (43)
MeWo 81(4) 64(16) 53 (5) 202 (34)
O-mel 117 ( - 7 ) 122 (17) 22 ( - 5 ) NT
Ba-H 99 ( -1 2 ) 116 (42) 51 (27) 196 (25)
M elanom a cells were incubated with 500 IU/ml y-IFN (optimal concentration) for 24 h r.-2Fluorescence 
intensity expressed as the channel number representing maximal fluorescence intensity. Channel numbers are 
plotted on a logarithmic scale.-3In parentheses: difference in channel number with melanoma cells cultured in the 
absence o f 7 -IFN. Control values of melanoma cells tested in the absence of MAbs varied between channel 
numbers 21 and 42.
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TABLE III -  THE EFFECT OF RETINOIC ACID (10"6 M) ON THE EXPRESSION OF ANTIGENS DETECTED BY
AMF-7 AND CLASS-I AND CLASS-II MHC ANTIGENS
Melanoma
culture1
AMF-7 
Channel No.
HLA-DR 
with maximal
HLA-DQ
fluorescence
HLA-A.B.C
intensity^
L-2 125 (~7)3 147 ( -1 2 ) 35 (3) 210 ( — 16)
BK 84 ( -8 ) 122 (93) 24(1) 185 (24)
Hor 73 ( -7 ) 88 (67) 24 ( -8 ) 2 1 1 (8 )
NKI-4 131 (-1 3 ) 150 (6) 36 ( -5 ) 205 ( -  7)
'Melanoma cells were incubated with 10"6 m  retinoic acid (optimal concentration) for 24 hr. ^ F luorescence 
intensity is expressed as channel number representing maxima! fluorescence intensity. Channel numbers are 
plotted on a logarithmic scale.-3In parentheses: difference in channel number with melanoma cells cultured in the 
absence of retinoic acid. Control values of melanoma cells tested in the absence of MAbs varied between channel 
numbers 21 and 35.
inhibited the adhesion of all 14 melanoma cell cultures 
tested to both plastic surfaces and monolayers of vas­
cular endothelial cells (Table IV). Average inhibition 
was 59% (39-79%). In contrast, AMF-2, AMF-8, PA­
LM 1 and the MAbs directed against HLA-DR(Q5/13), 
HLA-DQ (SPV-L3) and HLA-A,B,C (W6/32) had no 
effect. Moreover, AMF-6, which is directed against a 
melanoma-associated sulfated proteoglycan, had no 
significant effect, although cytoplasmic spreading was 
somewhat inhibited. PA-LM2, which was selected be­
cause it stains melanoma cells in frozen tissue sections 
and which reacted with an antigen consisting of 2 
bands in immunoblots with estimated MWs of 100 and 
95 kDa respectively (Ruiter et al.9 1985), also inhib­
ited the adhesion of melanoma cells. PA-LM2 did not 
affect the adhesion of 2/14 melanoma cultures. How­
ever, immunofluorescence studies showed that these 2 
melanomas failed to react with PA-LM2. This is in 
line with data obtained by Ruiter et aL (1985) who 
showed that PA-LM2 did not stain all melanomas in 
frozen sections. PAF-1, which was selected for its 
capacity to inhibit the adhesion of melanoma cells, and 
which reacted with the same antigen as detected by 
AMF-7, also inhibited the adhesion of cells from all 14 
melanomas tested. This selection procedure is thus 
shown to be very effective in obtaining MAbs directed 
against cellular adhesion molecules. AMF-7 and PAF-
1 also inhibited the adhesion of melanoma cells derived 
from 4 different cultures to monolayers of vascular 
endothelial cells. Average inhibition was somewhat 
lower (51%) (32-65%) than that observed in adhesion 
to plastic surfaces. Finally, adhesion of cultured skin 
fibroblasts, which do not express the antigen(s) de­
tected by AMF-7, PA-LM2 and PAF-1, was not inhib­
ited by these MAbs. In addition to its adhesion- 
inhibitory effects, AMF-7 also delayed cytoplasmic 
spreading of the cells which did adhere. After 4 hr
incubation, a relatively large proportion (>25%) of 
the adherent cells were still rounded up and not spread 
out. A similar but less marked delay in cytoplasmic 
spreading was also observed with AMF-6 (data not 
shown).
Correlation between the expression of the antigen 
detected by AMF-7 and adhesion
In the above adhesion experiments, various mela­
noma cultures varied in their degree of adhesion. The 
majority of melanoma cells adhered efficiently during 
the 4 hr test period and in general 70-80 % of the cells 
were attached and spread out (Table V). Some cell 
lines, like MEWO and GEVA, however, adhered very 
poorly. After 4 hr incubation, only 10-20% of the cells 
attached and it took 10 hr before 70-80% of cells 
adhered. In order to determine whether there was a 
relation between the degree of expression of the anti­
gen reacting with AMF-7 and the capacity to adhere to 
plastic surfaces, both parameters were evaluated. Ta­
ble V shows that there is no correlation between the 
quantity of the antigen expressed on the cell surface, 
as determined by FACS analysis, and the capacity of 
the cells to adhere* The GEVA cells, which adhere 
very poorly, expressed abundant antigen detected by 
AMF-7 (Table V). In contrast, the short-term mela­
noma culture B-K, which adhered very efficiently, 
expressed relatively low quantities of the antigen. This 
indicates that although the antigen detected by AMF-7 
is strongly associated with cell-substrate and cell-cell 
adhesion, other melanoma surface antigens with adhe­
sion properties also contribute to the adhesion of mel­
anoma cells.
Analysis o f extracellular adhesion plaques deposited 
by melanoma cells
Melanoma cells were grown on glass cover slips for 
24-48 hr and analyzed for the presence of adhesion
TABLE IV -  EFFECTS OF MAbS AGAINST MELANOMA SURFACE DETERMINANTS AND CLASS-I AND CLASS-II MHC ANTIGENS ON THE
ADHESION OF MELANOMA CELLS TO PLASTIC OR ENDOTHELIAL CELLS
MAb 
antibody added
% Inhibition of adhesion
Plastic Endothelial cells
Melanoma cells 
(mean ±  SD 14 melanomas) Fibroblasts
Melanoma cells 
(mean ± SD 5 melanomas)
AMF-2 12±3 4 14 +  3
AMF-6 2+4 —5 4 +  2
AMF-7 59±5 ' 9 51 +  6
PA-LM1 1 ±5 NT 2 +  2
PA-LM2 40 ±14 NT 42 ± 9
PAF-1 50+4 - 8 45 +  5
Q 5/13 —4±3 - 8 —2 ± 3
W6/32 3 ±4 2 3 ± 3
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TABLE V -  EXPRESSION OF ANTIGEN DETECTED BY AMF-7, ADHESION AND MORPHOLOGY OF THE
MELANOMA CELLS
Melanoma
culture
Expression*
AMF-7
% Cells attached
Morphology
4 h 10 h
O-rnel 124 45 >80 Spindle-shaped
Ba-H 111 70 NT Fibroblast-like
DO 65 75 NT Epithelioid
GEVA 158 15 70 Spindle-shaped
Keu 154 15 65 Fibroblast-like
BK 75 80 NT Epithelioid
MeWo 72 5-10 70 Spindle/epithelioid
NKI-4 144 80 NT Epithelioid
1 Fluorescence intensity expressed as the channel number representing maximal fluorescence intensity. Channel 
numbers are plotted on a logarithmic scale.
plaques. The high-MW proteoglycan, as detected by 
AMF-6 and the antigen detected by AMF-2, were 
abundant in the adhesion plaques that were deposited 
predominantly along cell membranes (Fig. 3atb). 
AMF-7 was also equally distributed in the extracellular 
adhesion plaques (Fig. 3c). In contrast, Class-I and -II 
MHC antigens and the antigen detected by 96,5 were 
absent (not shown). This indicates that membrane sur­
face antigens detected by AMF-2, AMF-6 and AMF-7 
are also secreted in the extracellular adhesion plaques, 
illustrating that these molecules are also components 
of the extracellular matrix.
The effects of MAbs on the chemotactic motility o f 
melanoma cells
Adhesion of migrating tumor cells to vascular en­
dothelium is an important step in metastasis (Kramer 
andNicolson, 1979; Kramer etaL, 1980; Terranovaef 
aL, 1983). After the cells adhere, they invade the 
endothelial cell layer, the underlying basement mem­
brane and tissues. This migration of melanoma cells 
may be a unidirectional mode of locomotion along a 
path of preferential adhesion (Carter, 1965). It may 
occur through gradients of fibronectin (Birdwell etaL, 
1978; Kramer et aL , 1980). High concentrations of 
fibronectin are present in the sub-epithelial, basal 1am- 
inal part of the endothelial lining of blood vessel walls, 
whereas low levels are found on the apical surfaces of 
endothelial cells (Birdwell et aL, 1978; Kramer et aL , 
1980). Therefore, we investigated the effect of AMF- 
7 and other MAbs on motility and migration of NKI-4 
melanoma cells induced by fibronectin. Preliminary 
data show that fibronectin-induced chemo taxis and 
chemokinesis are strongly inhibited by AMF-7 (Table 
VI). MAbs AMF-6 and, to a lesser extent W6/32 (anti- 
class-I HLA), also exerted inhibiting effects. Q 5/13 
(anti-HLA-DR) and AMF-8 were ineffective. Only 4- 
7% of the NKI-4 cells migrated through the filter 
under the influence of a fibronectin gradient (chemo- 
taxis) whereas this percentage varied between 1 and
2 % for chemokinesis. Spontaneous migration was neg­
ligible (less than 20 cells passed the filter). This indi­
cates that the antigen detected by AMF-7, designated 
melanoma-associated cellular adhesion molecule-1 
(MACAM-1) is not only associated with adhesion of 
melanoma cells to vascular endothelium but also plays 
a role in the motility and migration of these cells. The 
high-MW proteoglycan does not significantly affect 
adhesion but blocks chemotactic and chemokinetic mo­
tility of melanoma cells.
DISCUSSION
We describe here MAbs that react with melanoma 
cell-surface antigens associated with biological func­
tions of human melanoma cells. MAbs AMF-7 and 
PAF-1 detect a melanoma-associated cellular adhesion 
molecule designated MACAM-1. MAb AMF-6 pre­
cipitates a molecular complex consisting of 2 bands 
with MWs of >450 and 250 kDa, similar to the 
sulfated proteoglycan described by Natali et aL (1981) 
and Bumol and Reisfeld (1982). AMF-6 and AMF-7 
were initially selected by virtue of their ability to 
inhibit the anti-melanoma reactivity of cytotoxic T-cell 
clones isolated from mixed lymphocyte cultures and 
mixed lymphocyte melanoma cell cultures (De Vries 
and Spits, 1984). PAF-1 was selected because it inhib­
its adhesion of melanoma cells to plastic surfaces. 
AMF-6 and AMF-7 react as far as tested with all 
melanomas both in tissue culture and in frozen sec­
tions. AMF-7 only showed significant cross-reactivity 
with a certain proportion of nevi and endothelial cells 
of small vessels, whereas endothelial cells of larger 
vessels and cultured vascular endothelial cells derived 
from umbilical veins were negative. The antigen de­
tected by AMF-7 is a complex molecule. Under non­
reducing conditions, it consists of 2 components with 
MWs of 150 and 90 kDa. In a reduced state the molec­
ular complex consisted of 4 moieties with MWs of 
120, 45, 29 and 25 kDa (data not shown). An antigen 
similar to MACAM-1 has been described by Mitchell 
et aL (1980) AMF-6 was found to cross-react with 
most nevi and with perineurium. The antigen detected 
by AMF-7 is trypsin-resistant whereas the melanoma- 
associated proteoglycan is trypsin-sensitive (data not 
shown). Neither antigen could not be modulated by 7 - 
IFN or by retinoic acid. In contrast, these immune 
modulators had differential effects on induction or 
enhancement of expression of HLA-DR and HLA-DQ. 
Expression of HLA-DR was generally enhanced by 7 - 
IFN but expression of HLA-DQ could not be induced 
in 3/9 melanomas (HOR, MEWO and O-mel). Reti­
noic acid significantly enhanced HLA-DR expression 
in 3/4 melanomas, but did not induce HLA-DQ. This 
suggests that the expression of HLA-DR and HLA-DQ 
on melanoma cells is independently regulated. Al­
though in some melanomas cap formation was ob­
served, neither MACAM-1 nor proteoglycan were 
readily modulated by incubation with an excess of 
antibody. Patch formation was generally observed after 
prolonged culture in the presence of AMF-6 and AMF- 
7. This indicates that these antigens are laterally mo-
FUNCTIONS OF MELANOMA ANTIGENS 471
TABLE VI -  INHIBITION OF FIBRONECTIN-INDUCED CHEMOTAXIS 
AND CHEMOKINESIS BY MAbs DIRECTED AGAINST MELANOMA 
SURFACE ANTIGENS AND CLASS-I AND CLASS-II MHC ANTIGENS
ON NKI-4 CELLS
MAb'
% Inhibition (mean ±  SD 3 experiments)
Chemotaxis Chemokinesis
AMF-6 52 +  8 47 ±7
AMF-7 90±3 95 ±2
AMF-8 5 ± 2 15+5
W6/32 28+4 34+4
Q5/13 9+ 2 14 + 5
'M Abs were added at a concentration of 10 ¿tg/ml of purified antibody.
tile. Similar patch-formation has been reported for a 
large variety of integral membrane proteins (Nicolson, 
1976). Whether MACAM-1 and proteoglycan are in­
deed integral membrane constituents is presently being 
investigated.
Interestingly, we found that MACAM-1 was associ­
ated with the adhesion (and cytoplasmic spreading) of 
melanoma cells to plastic surfaces and monolayers of 
vascular endothelial cells obtained from umbilical 
veins. AMF-6 only delayed cytoplasmic spreading (as 
reported by Reisfeld et al,, 1984), but did not signifi­
cantly affect adhesion.
In a 4-hr assay AMF-7 blocked adhesion of approx­
imately 60% of melanoma cells to plastic and 50% of 
these cells to endothelial cells. Adhesion of migrating 
tumor cells to vascular endothelium is an important 
step in hematogenic metastasis (Fidler and Nicolson, 
1980; Nicolson, 1982,1984) followed by extravasation 
and invasion of endothelium and underlying basement 
membrane and tissues (Kramer and Nicolson, 1979; 
Kramer et al., 1980; Terranova et al., 1983). Although 
tumor cells probably utilize several mechanisms to 
penetrate normal tissue during invasion (Nicolson, 
1982), active cell motility contributes also to the inva­
sive process (Poste and Fidler, 1980; Haemmerli, 1982; 
Volk et al. , 1984). Preliminary experiments showed 
that AMF-6 and AMF-7 inhibited the fibronectin-in- 
duced chemotactic and chemokinetic motility of mela­
noma cells, indicating that both antigens are associated 
with migration of melanoma cells. Experimental sys­
tems have shown that MAbs which block adhesion of 
tumor cells in vitro also inhibit metastasis in vivo 
(Vollkers and Birchmeier, 1983a) and that MACAM-1 
and proteoglycan are associated with migration of mel­
anoma cells; it is therefore tempting to speculate that 
these antigens play a role in hematogenic dissemina­
tion of human melanoma. This is supported by the 
distribution of MACAM-1 in frozen tissue sections. 
Primary melanoma tumors are stained heterogeneously 
and contain a considerable number of AMF-7-negative 
melanoma cells. In contrast, microsatellites and distant 
métastasés stained homogeneously in all instances.
MAb/PAF-1, which was selected by screening hy- 
bridoma supernatants for their capacity to inhibit adhe­
sion of melanoma cells to plastic, detected the same 
antigen as AMF-7, indicating that this screening
F ig u r e  3 -  Adhesion plaques deposited by  melanoma cells 
(L-2) on glass cover-slips. Staining with AMF-2 (a), AMF-6 
(b) and AMF-7 (c).
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method is effective for obtaining MAbs reacting with 
MAC AMs. This has already been reported for experi­
mental systems by Vollkers and Birchmeier (1983a, b) 
who showed that MAbs against murine B16 mela­
noma, selected for their capacity to block adhesion of 
B16 melanoma cells to plastic, were also effective in 
reducing experimental lung metastasis in vivo. In con­
trast to AMF-7 which reacts preferentially with mela­
noma cells, these anti-B16 antibodies, however, cross­
reacted with a large variety of other malignant and 
virally transformed cells including human melanoma. 
Adhesion was also inhibited by MAb PA-LM2 which 
detects a melanoma-associated antigen consisting of 2 
components with MWs of 100 and 95 kDa. PA-LM2 
probably detects an antigen other than MACAM-1 
since it does not react with all melanomas (Ruiter et 
al. , 1985). Inhibition of adhesion observed with AMF- 
7, PA-LM1 and PAF-1 was never complete. Maximal 
inhibitions of 80% (with an average of 60%) were 
obtained, which suggests that other adhesion mole­
cules also contribute to the adhesion of melanoma 
cells. This is supported by the lack of correlation 
between expression of MACAM-1 and the capacity of 
the various melanoma cells to adhere. Indeed, it has 
been reported that other melanoma-associated adhe­
sion molecules are expressed on human melanoma 
cells (Vollkers and Birchmeier, 1983a,b\ Dippold et 
a l 1984; Cheresh et al., 1985). Recently, ganglio- 
sides GD2 and GD3, which are strongly expressed on 
cells of neurectodermal origin, were found to be asso­
ciated with melanoma cell-substrate interaction (Cher­
esh et a l ,  1985), Addition of an MAb directed against 
ganglioside GD3 to attached melanoma cells resulted 
in a rounding-up and detachment of these cells (Dip­
pold et al., 1984). The gangliosides GD2 and GD3 are 
not only major components of the plasma membrane, 
but are also deposited on adhesion plaques at the inter­
face between the melanoma cells and the substratum 
to which these cells are attached (Cheresh et al., 1985). 
Similar adhesion plaques containing high-MW proteo­
glycan and antigens detected by AMF-2 and AMF-7 
were observed to be deposited on glass coverslips after 
melanoma cells were removed with EDTA. Class-I 
and Class-II MHC antigens, which are major mem­
brane constituents of melanoma cells, and the mela- 
noma-associated antigen detected by 96.5 (Hellstrom 
et a l 1982) were absent from adhesion plaques. This 
indicates that MACAM-1, the high MW proteoglycan, 
and the antigen detected by AMF-2 are also compo­
nents of the extracellular matrix produced by mela­
noma cells.
AMF-6 and AMF-7 were selected on the basis of 
their capacity to inhibit the reaction of cytotoxic T- 
lymphocyte (CTL) clones that preferentially lyse hu­
man melanoma cells (De Vries et al., 1984). We have 
shown that this blocking reactivity was specific and 
have concluded that these CTL clones have receptors 
for the high-MW melanoma-associated proteoglycan 
and MACAM-1, which allows them to interact with 
human melanoma cells.
Our results indicate that MACAM-1, as detected by 
AMF-7 (and PAF-1), and the proteoglycan detected by 
AMF-6 are associated with biological functions of hu­
man melanoma cells that may play a role in the hema­
togenic dissemination of malignant melanoma. Iden­
tification of other MAC AMs, and particularly their 
“counter-structures” on endothelial and other tissues, 
are relevant for gaining better insight into the process 
of metastasis in human melanoma.
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